baber/WOPTO huggingface dataset:
Patent NZ-256137-A (NZ)
Title: Urea granule production; process in which a urea melt or solution also containing a granulation additive is sprayed into a fluidised bed of urea particles
Inventor: KAYAERT ANDRE FIRMIN
IPC: C05C1/02
Filed: 1993-08-05
Abstract: PCT No. PCT/NL93/00167 Sec. 371 Date May 25, 1995 Sec. 102(e) Date May 25, 1995 PCT Filed Aug. 5, 1993 PCT Pub. No. WO94/03267 PCT Pub. Date Feb. 17, 1994A process for the production of urea granules from a melt or solution of urea by spraying the urea melt or solution, which also contains as granulation additive formaldehyde, methylolureum, urea-formaldehyde precondensates, or hexamethylenetetramine, in the form of very fine droplets into a fluidized bed of urea particles, in which process the granulation additive is added to the melt or solution prior to the granulation at such a stage so that the mixture of the granulation additive and the urea melt or solution has a contact time of at least 20 sec., but not more than 20 min.
Patent NZ-263668-A (NZ)
Title: Bombesin antagonist peptides and compositions thereof
Inventor: SCHALLY ANDREW VICTOR
IPC: A61K38/08
Filed: 1994-03-07
Abstract: Pseudopeptides comprising a peptide of formula I: X-A1-A2-Trp-Ala-Val-Gly-His-Leu-psi-A9-Q wherein X is hydrogen, a single bond linking the alpha amino group of A1 to the gamma carboxyl moiety on the 3-priopionyl moiety of A2 when A2 is Glu, or a group of formula R1CO- wherein R1 is selected from the groups consisting of a) hydrogen, C1-10alkyl, phenyl or phenyl-C1-10-alkyl, p-HI-phenyl, p-HI-phenyl-C1-10-alkyl, naphthyl, naphthyl-C1-10-alkyl, indolyl, indolyl-C1-10-alkyl, pyridyl, pyridyl-C1-10-alkyl, thienyl, thienyl-C1-10-alkyl, cyclohexyl or cyclohexyl-C1-10-alkyl, where HI=F, Cl, Br, OH, CH3 or OCH3; b) N(R2)(R3)-, wherein R2 is hydrogen, C1-10alkyl, phenyl or phenyl-C1-10-alkyl, R3 is hydrogen or C1-10alkyl; c) R4O-, wherein R4 is C1-10alkyl, phenyl or phenyl-1-10-alkyl; A1 is a D- or L- amino acid residue selected from the group consisting of Phe, p-HI-Phe, pGlu, Nal, Pal, Tpi, unsubstituted Trp or Trp substituted in the benzene ring by one or more members selected from the group consisting of F, Cl, Br, NH2 or C1-3alkyl; or A1 is a peptide bond linking the acyl moiety of R1CO- to the alpha amino moiety of A2; A2 is Gln, Glu[-], Glu(Y) or His, wherein [-] is a single bond linking the gamma carboxyl group of A2 when A2 is Glu with the alpha amino group of A1 where X is a single bond, Y is -OR5 or -N(R5)(R6) wherein R5 is hydrogen, C1-3 alkyl or phenyl; R6 is hydrogen or C1-3alkyl; and R7 is hydrogen, C1-3alkyl or -NHCONH2; Leu-ypsi- is a reduced form of Leu wherein the C=O moiety of Leu is instead -CH2- such that the bond of this -CH2- moiety with the alpha amino moiety of the adjacent A9 residue is a pseudopeptide bond; A9 is Tac, MTac, or DMTac; and Q is NH2 or OQ1 where Q1 is hydrogen, C1-10alkyl, phenyl or phenyl-C1-10-alkyl; and the pharmaceutically acceptable acids or salts thereof.
Patent NZ-266368-A (NZ)
Title: Container closure; moulded bottle stopper made from a styrene block copolymer and a blowing agent
Inventor: BURNS DENNIS L
IPC: C08J9/10
Filed: 1994-05-05
Abstract: A molded closure for a liquid container comprising a thermoplastic elastomer and a blowing agent. The molded closure is particularly suitable for use as a synthetic wine cork in a wine bottle. The molded closure does not permit passage of oxygen into the container, does not absorb oxygen from the contents of the container, can be removed from the container using a corkscrew without significant expansion, crumbling or disintegration, does not significantly taint a liquid in the container, permits the container to be placed horizonzally immediately after insertion of the molded closure, and can permanently retain printed matter on its surface. <IMAGE>
Patent NZ-278575-A (NZ)
Title: Dental fluid suction unit; comprises a flexible paper tube consisting of two sections joined by a concertina section
Inventor: LANGE-MICKEL GERTRUD
IPC: A61L31/00
Filed: 1995-01-21
Abstract: PCT No. PCT/DE95/00087 Sec. 371 Date May 1, 1996 Sec. 102(e) Date May 1, 1996 PCT Filed Jan. 21, 1995 PCT Pub. No. WO95/20364 PCT Pub. Date Aug. 3, 1995A flexible paper tube, in particular a throw-away saliva suction unit for dentistry, comprises two tubular sections integrally connected to each other via a bellows and is characterized in that the paper tube (2, 6) is constructed from multi-layer paper, in particular having 3 through 15 layers and preferentially 4 to 10 layers of thickness 0.07 to 0.35 mm, in particular 0.1 to 0.2 mm and with a wall thickness between 0.2 to 2.5 mm, preferentially 0.5 to 1 mm. The fluting and folding of the bellows is preferentially done before hardening of the glued paper layers. The paper tube (2, 6) in accordance with the invention guarantees that the tube passage is not reduced in size when flexing of the tube through bending of the bellows.
Patent NZ-292269-A (NZ)
Title: Heterocyclic amine derivatives and medicaments therefrom
Inventor: CHOKAI SHOICHI
IPC: A61K31/444
Filed: 1995-09-08
Abstract: A pharmaceutical composition comprising a compound of the following general formula ÄIÜ or its salt. <CHEM>  wherein R<1> represents aryl or a heteroaromatic group. R<2> represents hydrogen, alkyl, alkenyl, cycloalkyl, cycloalkylalkyl, hydroxyalkyl, haloalkyl, alkoxy, alkylthio, amino, monoalkylamino, dialkylamino, or phenyl. R<3> and R<4> independently represent hydrogen or alkyl or R<3> and R<4> taken together with the adjacent N atom represent a 5- through 7-membered cyclic amino group. A represents C2-10 alkylene. W represents O, S, or (CH)n (where CH may be substituted by alkyl; n is an integer of 0, 1 or 2). X, Y, and Z may be the same or different and each represents CH (which may be substituted by alkyl), or N. Provided, however, that the case in which X, Y, and Z concurrently represent CH is excluded. The compound of the invention has excellent neuronal death inhibitory activity and is useful as a therapeutic drug for cerebrovascular diseases.
Patent NZ-311202-A (NZ)
Title: A trap for catching and killing of small animals
Inventor: HANSSON GORAN
IPC: A01M23/30
Filed: 1996-06-12
Abstract: PCT No. PCT/SE96/00771 Sec. 371 Date Dec. 19, 1997 Sec. 102(e) Date Dec. 19, 1997 PCT Filed Jun. 12, 1996 PCT Pub. No. WO97/00607 PCT Pub. Date Jan. 9, 1997A trap for trapping and killing small animals such as rats and mice, is described. The trap comprises a stand, a pivoting clamp, journalled in the stand around a first axis. The clamp may be strained against the action of a spring which may be released by a releasing mechanism from a first, loaded position, when an animal acts upon the releasing mechanism. When released, the clamp immediately swings, acted upon by the spring, to a second position, where it hits and kills the animal. The clamp, extending from the first axis is provided with a first arm and a second arm. A first fastening point of the spring is provided at an end that is turned from the first axis of the first arm. The second fastening point of the spring is provided at the stand. The force line between the two fastening points of the spring runs through or in the vicinity of the first axis such that the spring exerts little or no or torque in the direction towards the second position of the clamp. The trap is primarily characterized in that the releasing mechanism is journalled around the second axis in the stand, forming a first arm portion designed like a cap above a vessel for bait. A second arm portion acts upon the first arm of the clamp when the cap is lifted by the animal.
Patent NZ-323140-A (NZ)
Title: Unified end-to-end security methods and systems for operating on insecure networks
Inventor: ATALLA MARTIN M
IPC: H04L9/08
Filed: 1996-11-01
Abstract: Secure transmission of a message is achieved by using a one-time encryption key derived at the receiver and the sender from information present at both the sender and the receiver, but wherein the information from which the encryption key is derived is not transmitted between the sender and the receiver. A plurality of bytes, known as a master signature, is randomly generated and stored at the sender, wherein each byte is uniquely identified by an address. A first random subset of this plurality of bytes, called an access signature, and the addresses in the master signature of the bytes in this access signature, are stored at the receiver. To generate an encryption key, the receiver selects a second random subset of bytes, known as a session signature, from the access signature and sends the addresses in the master signature of the bytes in this session signature to the sender. The sender uses these addresses to identify the bytes in this session signature which bytes are used at both the sender and the receiver to derive the encryption key. If desired, these bytes can be used directly as the encryption key but preferably, these bytes are passed through a session signature-to-session key converter using an irreversible algorithm to generate a one-time encryption key to be used to encrypt the message to be sent between the sender and the receiver. The master signature can also be derived from the digitized video image of the user, which allows a card containing the master signature to be used as described above but also with a video monitor to visually identify the user.
Patent NZ-332697-A (NZ)
Title: Methods for manufacturing molded sheets having a high starch content
Inventor: ANDERSEN PER J
IPC: B29C48/91
Filed: 1997-04-09
Abstract: Methods are disclosed for manufacturing sheets having a starch-bound matrix reinforced with fibres and optionally including an inorganic mineral filler. Suitable mixtures for forming the sheets are prepared by mixing together (10) water, unmodified and ungelatinized starch granules, a cellulosic ether, fibres, and optionally an inorganic mineral filler in the correct proportions to form a sheet having desired properties. The mixtures are formed into sheets by passing them between one or more sets of heated rollers (40) to form green sheets. The heated rollers (40) cause the cellulosic ether to form a skin on the outer surfaces of the sheet that prevents the starch granules from causing the sheet to adhere to the rollers (40) upon gelation of the starch. The green sheets are passed between heated rollers (50) to gelatinize the starch granules, and then to dry the sheet by removing a substantial portion of the water by evaporation.
Patent NZ-333317-A (NZ)
Title: Absorbent article having a composite breathable backsheet comprising a liquid impermeable, vapour impermeable film and a nonwoven facing layer
Inventor: GOOD KRISTEEN ELAINE
IPC: A61F13/49
Filed: 1997-06-10
Abstract: An absorbent article includes a substantially liquid impermeable, vapor permeable composite backsheet, a liquid-permeable topsheet positioned in facing relation with the backsheet and an absorbent body located between the backsheet and topsheet. The composite backsheet includes a polymeric film of relatively low basis weight and a non-woven facing layer which enhances the strength of the composite backsheet and provides a cloth-like feel to the composite backsheet.
Patent NZ-333332-A (NZ)
Title: DNA sequences encoding phytases that release inorganic phosphorous from phytic acid of ruminal microorganisms like Selenomonas ruminantium and these are used in animal feed supplements
Inventor: CHENG KUO JOAN
IPC: A23K1/165
Filed: 1997-06-13
Abstract: Isolated and purified DNA encoding phytases derived from ruminal microorganisms are claimed. Preferred sources of phytases include Selenomonas, Prevotella, Treponema and Megasphaera. A purified and isolated DNA encoding a phytase of Selenomonas ruminantium JY35 (ATCC 55785) is also claimed. Recombinant expression vectors containing DNAs encoding the phytases and host cells transformed with DNAs encoding the phytases are also claimed. The phytases are useful in a wide range of applications involving the dephosphorylation of phytate.
Patent NZ-334701-A (NZ)
Title: Dihydropyrones and use in treating retrovirus infections and diseases
Inventor: BOYER FREDERICK EARL
IPC: C07D241/04
Filed: 1997-10-31
Abstract: The compounds of formula I may be used to treat infection or disease caused by a retrovirus.  The compounds may be used in combination with a HIV reverse transcriptase inhibitor, AZT or ddC. In formula I:  R1 is H, 2- or 3- or 4- (CH2)n' OR' or (CH2)n' N(R')2 where n' is 0 or 1 and wherein 2- or 3- or 4- refer to the point of substitution on the phenyl ring; R2 and R3 are independently H, OR, N(R)2, a straight or branched alkyl of 1-4 carbons, a cycloalkyl of 3-6 carbons, F, Cl, Br, NRCOR, COR, CON(R)2, OCOR, CO2R, NRSO2R, SO2N(R)2, NRSO3R, NRSO2N(R)2, NRCON(R)2, or R2 and R3 may be taken together to form a ring of 5-6 atoms optionally containing 1 or 2 heteroatoms; R4 is a straight or branched alkyl of 1-7 carbons, a cycloalkyl of 3-7 carbons, a heterocycle of 4-7 atoms containing 1-2 heteroatoms, or (CH2)n Ph, all of which may be optionally substituted by F, Cl, Br, R, OR, SR, N(R)2, CON(R)2, NRCOR, SO2R and COR; R5 is H, (CH2)nOR, (CH2)nN(R)2, (CH2)nNRCOR, (CH2)nOSO2N(R)2, (CH2)nOSO2R, (CH2)nNRSO2 N(R)2, OCH2CH2OR, NRCH2CH2OR, (CH2)nCN, (CH2)nCON(R)2, (CH2)nNRCON(R)2, C(CH3)2OR, (CH2)nCOR, (CH2)nNRSO2R, (CH2)nCO2R, O(CH2)nCO2R, OCON(R)2, NR(CH2)nCO2R, -(CH2)n-NR-CS-N(R)2, (CH2)n-NRSO2OR, wherein n is an integer of from 0 to 3; R6 is methyl, ethyl or isopropyl; R is independently H, a straight or branched alkyl of 1-5 carbons, a -(CH2)n-cycloalkyl wherein the cycloalkyl is of 3-6 carbons and wherein n is an integer of from 0 to 3, -(CH2)m-Ph, a (CH2)m-heterocycle wherein the heterocycle is of 5-6 atoms with 1-3 heteroatoms and wherein m is an integer of from 0 to 3, and wherein the (R)2 in N(R)2 may be a heterocycle containing the nitrogen, all optionally substituted by F, Cl, Br, =O, -CN, -CF3, OR', COR', N(R')2, CON(R')2, or NR'COR'; and R' is H, a straight or branched alkyl of 1-3 carbons, or Ph; and n" is an integer of from 1-2.
Patent NZ-503820-A (NZ)
Title: A delayed followed by immediate release drug delivery system containing a core and a coating
Inventor: LERNER E ITZHAK
IPC: A61K47/32
Filed: 1998-10-01
Abstract: A gastrointestinal delivery system is provided. The system comprises a drug in combination with a swellable core material, the core being surrounded by a water- insoluble or relatively water-insoluble coating material in which particulate water-insoluble material is embedded. When the delivery device enters the gastrointestinal tract, the particulate matter takes up liquid, thus forming channels interconnecting the drug-containing core with the outside of the delivery device. Through these channels liquid enters the core, which then swells to the point at which the coating is broken. When the integrity of the coating is destroyed, the core then disintegrates immediately releasing all or most of the drug at a specific site. By controlling parameters in the device, such as the core material, carrier material in the coating, and particulate matter, the location of release of the drug can be carefully controlled. Thus, provided also is a method of using the device for the treatment of disease by the release of drugs in the gastrointestinal tract in a location- and time-dependent manner.
Patent NZ-503920-A (NZ)
Title: Recovery of code lines after jam in cheque processing system
IPC: G06Q20/04
Filed: 2000-04-11
Abstract: A financial document (cheque) processing system is operated to assist the operator during exception recovery.  During exception recovery an original codeline, an encoded data string, and a recovery codeline associated with the financial document are obtained.  Any blank spaces from the original codeline, the encoded data string and the recovery codeline are stripped to provide a stripped original codeline, a stripped encoded data string and a stripped recovery codeline.  A number of characters of the stripped recovery codeline and a number of characters of the stripped original codeline are compared to determine if there is a match between the original codeline and the recovery codeline.  When there is a mismatch of characters between the stripped recovery codeline and the stripped original codeline, a number of characters of the stripped recovery codeline and a number of the characters of the stripped encoded data string are compared to determine if there is a match between the original codeline/encoded data string and the recovery codeline.
Patent NZ-506208-A (NZ)
Title: Wool treatment agent comprising organopolysiloxane and nonionic emulsifying agents with a specific HLB
Inventor: ISHIKAWA HIROKI
IPC: D06M15/643
Filed: 2000-08-08
Abstract: The agent is an aqueous emulsion composition consisting of; a) an amino group containing organopolysiloxane, b) a nonionic emulsifying agent with an HLB of less than 15, c) a nonionic emulsifying agent with an HLB of 15 or greater, and d) water. This aqueous emulsion composition is stable against ionic substances and is useful as an anti-shrinking agent.  Examples of the organopolysiloxane are given in the formula above, wherein; R indicates a substituted or unsubstituted monovalent C1-20 hydrocarbon group, and R1 is H or a monovalent hydrocarbon group.
Patent NZ-508306-A (NZ)
Title: Bridged indenopyrrolocarbazoles
Inventor: HUDKINS ROBERT L
IPC: A61P29/00
Filed: 1999-06-04
Abstract: Fused aryl and heteroaryl bridged indenopyrrolocarbazoles, methods for making said bridged indenopyrrolocarbazoles and their use as therapeutic agents for enhancing trophic factor-induced activities of trophic factor responsive cells, survival-promoting agents for other neuronal cell types, and in the treatment of disorders associated with decreased ChAT activity or the death or injury to spinal cord motorneurons.  The bridged indenopyrrolocarbazoles compounds also have utility in treating diseases associated with apoptotic cell death of the central and peripheral nervous system, immune system, inflammatory diseases, and may have utility in treatment of malignant cell proliferation.
Patent NZ-508828-A (NZ)
Title: Orientation of films to improve barrier and UV stability
Inventor: JOHNSTONE PETER
IPC: B29C61/00
Filed: 1999-06-23
Abstract: Disclosed is a method of treating plastics material fibres, filaments or film to improve their resistance to degradation by UV radiation and/or increase their resistance to gas (oxygen) transmissivity and an improved plastics material so treated, the method including stretching the fibre, filament or film beyond its yield point and allowing the film to at least partially relax.
Patent NZ-508835-A (NZ)
Title: Multi-frequency band antenna
Inventor: STOLLE MANFRED
IPC: H01Q5/10
Filed: 2000-05-04
Abstract: A multiband antenna having a first antenna device for a first frequency band range and having at least one second antenna device for a second frequency band range has the features of, the first antenna (3) and the last second antenna (9) are arranged such that they are integrated and interleaved in one another. Also, the associated dipole halves (3'a, 3"a; 9'a,9"a) of the at least two antennas (3,9) are designed to be at least electrically in the form of, or similar to, sleeves or boxes. In addition, the dipole halves of the at least two antennas are short circuited to one another at their respective mutually adjacent end (7'a, 7"a) and extend from there with different lengths depending on the frequency band range to be transmitted. Finally, the dipole halves are transmitting the respective lower frequency band range are located within the dipole halves (9'a, 9"a; 25'a, 25"a) which are intended for transmitting a respective higher frequency/range.
Patent NZ-512047-A (NZ)
Title: Synthesis of ester linked long chain alkyl moieties
Inventor: CADWALLADER DIANNE
IPC: C07C69/26
Filed: 2001-05-24
Abstract: A mixture of cetyl palmitate and cetyl myristate for use as an oral composition. The oral composition may be useful in the treatment of inflammatory ailments, in particular asthma.
Patent NZ-513402-A (NZ)
Title: Novel nucleosides and oligonucleotide analogues
Inventor: KANEKO MASAKATSU
IPC: C07H19/20
Filed: 2000-02-10
Abstract: An oligonucleotide analogue of the formula (1) wherein: R1 and R2 each represent one of: a hydrogen atom, a hydroxyl protecting group, a phosphoric acid group, or -P(R3)R4 wherein R3 and R4 each represent a hydroxyl group, a protected hydroxyl group, a mercapto group, a protected mercapto group, an amino group, an alkoxy group, an alkylthio group, a cyanoalkoxy group, or an amino group substituted by an alkyl group; A represents an alkylene group; B represents a purin-9-yl group, a 2-oxo-pyrimidin-1-yl group, a substituted purin-9-yl group or a substituted 2-oxo-pyrimidin-1-yl group having a substituent selected from the following a group: a hydroxyl group which may be protected, an alkoxy group, a mercapto group which may be protected, an alkylthio group, an amino group which may be protected, an amino group which may be substituted by an alkyl group, an alkyl group and a halogen atom.  Use of said oligonucleotide analogue as a primer, gene probe, or in any medicament is also covered.
Patent NZ-517190-A (NZ)
Title: Fatty acid desaturase gene from plants
Inventor: FEUSSNER IVO
IPC: C12N15/09
Filed: 2000-08-23
Abstract: An isolated nucleic acid sequence encodes a polypeptide with desaturase activity. The nucleic acid selected from: a) a nucleic acid sequence with the sequence shown in SEQ ID NO:1; b) nucleic acid sequence which as a result of the degeneracy of the genetic code are derived from the nucleic acid sequence of SEQ ID NO:1 and c) derivates of the nucleic acid sequence shown SEQ IDNO: 1 which encodes polypeptides with the amino acid sequences shown in SEQ ID NO:2 and which have at least 75 % homology at the amino acid level without substantially reducing the enzymatic activity of the polypeptides. Described are and transgenic plants and vector comprising the nucleic acid sequences. The sequences can be used in a process for the preparation of triglycerides with an increased content of unsaturated fatty acids or an increased content of saturated fatty acids and the preparation of saturated fatty acids by introducing the sequence into an oil-producing organism and isolating the oil produced.
Patent NZ-524069-A (NZ)
Title: Compositions and devices comprising bisphosphonates for vaginal delivery
Inventor: HARRISON DONALD C
IPC: A61K9/06
Filed: 2001-07-12
Abstract: Devices and compositions for vaginal delivery of bisphosphonates are disclosed. A targeted site delivery of bisphosphonates to the vagina using a medicated intravaginal device comprising a bisphosphonate composition formulated for transvaginal delivery is also disclosed. These devices and compositions are suitable for treatment of osteoporosis and related bone and skeleton diseases, for prevention of bone breakdown and loss of bone mass and strength by intravaginal administration of bisphosphonates to the vagina and transvaginal delivery of bisphosphonates to the general circulation.
Patent NZ-529401-A (NZ)
Title: 4 (phenyl-piperazinyl-methyl) benzamide derivatives and their use for the treatment of pain anxiety or gastrointestinal disorders
Inventor: BROWN WILLIAM
IPC: A61K31/495
Filed: 2002-05-16
Abstract: Disclosed are compound of formula I, wherein: R1 is a heterocyclic moiety, R2 is independently ethyl or isopropyl, and R3 is independently H or F. The compounds are used in the manufacture of medicaments for the treatment of pain, anxiety or functional gastrointestinal disorders.
Patent NZ-531447-A (NZ)
Title: A vehicle for ground cover rolls
Inventor: TOYE JONATHAN DALLAS
IPC: A01G1/00
Filed: 2004-03-01
Abstract: The vehicle, typically as a trailer, has split bearings allowing removal of rolls 2300, 2301 with mounted with spindle 112. A drive coupling is also provided for the spindle 112 to be driven.